|
|||||||||||||||
![]() |
|||||||||||||||
![]() |
|||||||||||||||
Sexually
Transmitted Diseases > Program Guidelines > Areas of Special Emphasis
Sections on this page:
INTRODUCTION SE-1Areas of special emphasis have direct relevance to multiple essential functions of a comprehensive STD prevention program and represent high priority prevention opportunities. Current areas of special emphasis are corrections, adolescents, managed care, STD/HIV interactions, syphilis elimination, and high risk populations. Programs will be involved in special emphasis areas to different degrees, depending on local priorities and epidemiology. All project areas need to address all areas of special emphasis. CORRECTIONSAdult and juvenile correctional populations are an integral part of the larger community. The majority of people in jails and juvenile facilities are housed there for short periods of time and quickly return to their communities. If infected and untreated for STD, they can potentially spread diseases to the larger population upon their release. Several studies have confirmed the high prevalence of STDs in jail populations and significant other jail-based infectious disease morbidity. At Riker's Island in New York, approximately 35% of female arrestees had reactive syphilis tests, 27% had chlamydia, and 8% had gonorrhea (Blank, 1997; Holmes, 1993). In Los Angeles juvenile detention facilities, approximately 27% of girls screened were positive for chlamydia, and nearly two-thirds of those testing positive for gonorrhea also tested positive for chlamydia. The majority of these infections were asymptomatic and would have gone undetected had screening not occurred (CDC Jail STD Prevalence Monitoring Project, 1998; Los Angeles County Juvenile Hall Prevalence Monitoring Project, 1997). An analysis of STD morbidity by the Chicago STD program found that nearly 25% of newly diagnosed syphilis cases were identified at the Cook County Jail (Skolnick, 1998). All arrestees are at high risk for STD infections and complications due to drug use and risky sexual behaviors characteristic of this population. STD testing and treatment in jail settings presents a unique public health and cost-effective opportunity to provide health services to a high risk, otherwise hard to reach population. Jail populations are transient, often use aliases and false identifying information, and rarely have a permanent address. For this reason, released offenders are difficult to locate and follow up for treatment and partner services. Furthermore, incarcerated populations often have minimal interaction with the health care system as a result of limited access to health care services and poor health care seeking behavior. Because STD infection is often asymptomatic, especially in women, STDs may remain unnoticed and untreated, leading to further transmission and costly complications. Programs are strongly encouraged to assess the need for STD services in adult and juvenile correctional facilities. One tool that can be used to accomplish this is the 1997 DSTD Correctional Health Care Assessment (Appendix SE-1). During an on-site assessment, programs may want to look at several variables, some of which are listed below.
Programs should also look at the sensitivity of their surveillance system, the demographics of STD infected individuals, and the resources that should be redirected from less productive activities and interventions and dedicated to activities in correctional settings. Based on the assessment, programs can decide the degree to which they will be involved with corrections. Appendix 2 lists some examples of correctional activities from low to high intensity. At a minimum, all programs should implement some of the low intensity activities. This will improve disease intervention, facilitate collaboration, and build an infrastructure between corrections and STD prevention programs. Several programs have developed special project coordinator positions or specialized corrections positions to improve and expand STD prevention and treatment services for high risk adult and juvenile correctional populations. These positions have been tailored to address the specific needs and circumstances found in these program areas. Some responsibilities of special project coordinators have included:
Recommendations
ADOLESCENTSAdolescents are among the groups at highest risk for STDs. Targeting adolescents for specific prevention activities can promote healthy sexual behaviors and help prevent the establishment of risky behaviors. Because barriers to care faced by adolescents are different from those of older individuals, STD prevention programs should develop specific prevention activities for adolescents. In general, STD prevention programs should seek to increase awareness and knowledge of STDs among adolescents, facilitate and increase access to care among adolescents, improve STD care offered to youth, and involve youth in prevention activities. Relevant STD information should be incorporated into HIV, reproductive, and comprehensive health education curricula, which could then be used by individuals or community groups who sponsor youth activities (e.g., adolescent health care providers, Boys and Girls Clubs, CBOs). The obstacles faced by adolescents that prevent them from utilizing categorical STD clinics should be evaluated and addressed, referrals by prevention partners to STD care should be facilitated, and availability of services to adolescents at risk for STDs should be increased. This could be accomplished by establishing services at new and existing locations and by utilizing newly available technology such as urine-based STD testing. Care providers serving youth should be encouraged to provide STD testing and counseling consistent with CDC guidelines, and STD staff should receive training to allow them to serve adolescents comfortably and competently. Programs should involve youth in programs as focus group leaders and peer educators. This requires the training of youth and an on-going effort on the part of the program. Having one person within an STD prevention program responsible for coordinating youth activities can help focus and coordinate the activities and avoid duplication of services. Programs should consider identifying a person to serve as "youth liaison" to prevention partners and to help develop and improve youth services. This individual could facilitate effective partnerships with agencies and organizations involved with youth. For example, partnership with the Comprehensive School Health Program Projects supported by CDC's Division of Adolescent and School Health would encourage the integration of prevention activities across organizations. STD rates among youth in detention facilities are usually high. Programs should provide testing for as large a percentage of youth in detention as is feasible. Adolescent girls are at higher risk for acquiring some STDs than adult women because of an immature cervix and because they are more likely to have had multiple partners over a shorter period of time. They are at higher risk than adolescent boys because they are more likely to have older male partners and those older partners may be more likely to have multiple partners. In addition, the relationship dynamic between adolescent girls and their adult male partners may prevent negotiation of condom use. Recommendations
MANAGED CAREAn important change in the health care delivery system in the United States is the growth in managed care arrangements. Managed care encompasses a complex array of structures ranging from highly-structured group and staff model health maintenance organizations (HMO) to more loosely-structured point of service (POS) products (CDC Managed Care Working Group, 1995). Since the early 1990s, all types of managed care organizations (MCOs) have seen considerable gains in enrollment. In 1996, for example, the total number of HMO members grew by an estimated 8.4 million people, to 67.5 million (American Association of Health Plans (AAHP), Managed Care Facts, 1998). In the public sector, many health departments are in some stage of transition from providing only directly delivered clinical services in categorical clinics to adding other delivery models that involve managed care. Medicaid recipients and uninsured patients have traditionally relied upon the public health clinic system. To control costs, many State Medicaid agencies have contracted with MCOs to care for eligible persons. Between 1991 and 1996, the number of Medicaid recipients enrolled in Medicaid managed care programs more than quadrupled, from 2.7 million to 13.3 million (Health Care Financing Administration, 1997). These changes will have an impact on the way in which STD prevention and control are conducted in both the public and private sectors (ASTHO, 1995). With more diagnostic and treatment services for STDs moving into the private sector, new partnerships are needed between MCOs and public health agencies to design and implement essential STD-related prevention services in innovative ways. Public health agencies and managed care organizations have the potential to work together to improve the health of the public that neither system could achieve alone (Institute of Medicine, 1997; Office of Inspector General, 1999). According to the IOM and other recent reviews (Gunn 1998; Gonen, 1999), managed care organizations may improve STD- elated prevention services in several ways. Managed care can facilitate the integration of STD care into primary care and prevention given its expanding reach into private and public sector coverage. This is particularly appealing because managed care and public health departments share a commitment to prevention. Some types of managed care, such as staff model plans, have a population-based perspective toward enrollees that may extend to the larger community. Managed care organizations have the potential to employ their information systems to monitor STD-related trends and have a greater accountability to both beneficiaries and purchasers through such mechanisms as performance measures. Other potential areas of collaboration include behavioral surveillance, laboratory practice, and health education (ASTHO, 1995). Although MCOs have the potential to benefit STD prevention and control, there are also countervailing forces that need to be considered. This includes, but is not limited to, differences between managed care and public health with respect to culture, mission, and legal obligations; increased competition and turbulence in managed care markets as MCOs try to survive ever-increasing health care costs; and competing costs and priorities for finite resources (Scholes, 1999). There is the potential for less collaboration if MCOs fail to invest in adequate data systems or fail to engage state and local public health agencies to help improve the health of their covered populations (ASTHO, 1995). Finally, less collaboration will result if MCOs fail to understand the wide range of services encompassed by STD prevention. As indicated by a report from the Jacobs Institute (1997), STDs have not been a high priority for most MCOs, and MCOs vary widely in their technical ability to provide services for which they do not see demonstrated cost saving. This is a critical area in need of considerable work. Since 1992, CDC established the STD Prevention Partnership, a coalition of national organizations that "share concern about the continuing spread of STDs, including HIV." The Partnership's membership includes national trade organizations for managed health care plans (e.g., American Association of Health Plans). The mission of the Partnership is to support and encourage partnerships among public, private, and voluntary sections with the aim of developing and implementing plans to reduce the incidence and effects of STDs (STD Prevention Partnership, 1996). During the past several years, specific programmatic activities in managed care and STDs have been initiated. Three recent developments are worth noting here. One is the Health Plan Employer Data and Information Set (HEDIS) 2000 performance measure on chlamydia screening in women (NCQA, 1999). This measure assesses the "percentage of Medicaid and commercially enrolled women between the ages of 15 and 25 years, who are sexually active, who have received at least one screening test for chlamydia during the reporting year." The measure is important because it represents the first time that STDs are included to assess how well managed care organizations are performing. A second development is the "Purchasing Specifications for Services for Sexually Transmitted Diseases." These managed care purchasing specifications were developed by George Washington University in collaboration with the Division of STD Prevention. They define STD services, delivery of services, and quality of care that should be included in any contract between STD prevention programs and MCOs, Medicaid, or other providers of STD services (Center for Health Policy Research, 1998). The following websites will provide sample purchasing specifications (http://www.gwu.edu/~chsrp/) and information on STD memoranda of understanding (http://www.gwumc.edu/chpr/mcph/moustd.pdf). The third activity is a project examining managed care's role in STD prevention and control, which was conducted by investigators at Group Health Cooperative at Puget Sound Center for Health Studies, in collaboration with CDC and AAHP. The objectives were to identify ways in which current managed care environments can become more productively involved in the emerging STD health care agenda, and to make specific recommendations that are practical 'next steps' toward achieving effective policies and programs from managed care and public health perspectives. Based on findings from the published literature and qualitative interviews, recommendations were grouped by stages of change (i.e., increased interest in STD prevention, planning for action, taking action, building sustainability) and were directed at MCOs, national MCO trade and professional organizations, and public health agencies. Recommendations
STD/HIV INTERACTIONIn the presence of STDs, there can be increased HIV infection transmission to persons not infected and an accelerated progression of HIV disease in the infected person. In addition, in the presence of HIV, there may be an alteration in the natural history, diagnosis, or response to therapy of STDs (Wasserheit, 1992). Studies have demonstrated the increased risk of HIV seroconversion to be associated with both genital ulcer disease and non- ulcerative STDs (Telzak, 1993; Levine, 1998). HIV transmission has been associated with concurrent infection with syphilis, herpes, chancroid, gonorrhea, or chlamydia. Treatment of STDs can reduce the prevalence and magnitude of viral shedding (Cohen, 1997). Despite sound scientific evidence for treating STDs to prevent HIV, the question remains how to best structure such an intervention. To effectively target STD treatment for HIV prevention, an intervention must target populations with a high incidence of STDs and HIV. Because STDs increase both infectivity and susceptibility, detection and treatment should target both HIV infected and high-risk HIV uninfected persons. An intervention might include such elements as referral of HIV infected persons for care (including screening, diagnosis, and treatment for STDs), increasing access to care for STD clients, promoting risk assessment and screening of persons asymptomatically infected with STDs, rapidly diagnosing symptomatic STDs, ensuring effective treatment for STDs, and counseling, follow-up, and partner services for persons with STDs. Programs should explore the feasibility of linking STD diagnostic and treatment services with HIV counseling, testing, and treatment services in a wide variety of settings. These settings may include STD clinics, HIV testing and counseling sites, HIV care sites, drug treatment sites, prenatal and family planning clinics, correctional facilities, emergency medical and urgent care facilities, adolescent clinics, primary care settings in the private sector, and community health centers. As a part of linking STD and HIV services, program managers should review the epidemiology of STD and HIV trends in their community, identify where high risk persons are currently accessing health care and other social services, what types of services are available, and what gaps exist in available services. The Advisory Committee for HIV and STD Prevention (ACHSP) reviewed data on the relation between curable STDs and the risk for sexual transmission of HIV. ACHSP considered that the evidence was strong that early detection and treatment of other STDs is an effective strategy for preventing sexually transmitted HIV. The ACHSP has recommended the following.
Recommendation
SYPHILIS ELIMINATIONWith the large decrease in primary and secondary syphilis occurring during the mid to late 1990s, the United States is faced with a unique opportunity to eliminate syphilis within its borders. Syphilis is easy to detect and cure, given adequate access to and utilization of care. Nationally, it is at the lowest rate ever recorded and it is confined to a very limited number of geographic areas. The last epidemic peaked in 1990, with the highest syphilis rate in 40 years. In 1998, over 50% of infectious (primary and secondary or P&S) syphilis cases were reported from only 28 (<1%) counties, the majority of which are in the South. In addition, where syphilis does persist in the U.S., it disproportionately affects African Americans living in poverty. Although the Black:White ratio for reported syphilis rates has decreased by almost one-half since the early 1990s, the 1998 P&S syphilis rate for non-Hispanic Blacks was still 34 times greater than that for non-Hispanic whites. Elimination of syphilis would have far-reaching public health implications because it would remove two devastating consequences of the disease –increased likelihood of HIV transmission and compromised ability to have healthy babies due to spontaneous abortions, stillbirths, and multi-system disorders caused by congenital syphilis acquired from mothers with syphilis. In addition, more than $996 million is spent annually as a result of syphilis. Eliminating syphilis in the United States would be a landmark achievement because it would remove these direct health burdens, and it would significantly decrease one of this Nation's most glaring racial disparities in health. The persistence of high rates of syphilis in the United States is a sentinel event identifying communities in which there is a fundamental failure of basic public health capacity to control infectious diseases and ensure reproductive health. In these areas, syphilis elimination will be the leading edge of a broader effort to begin rebuilding this capacity. Based on the repeatedly observed seven- to ten-year syphilis cycle, there is currently a narrow window of opportunity to eliminate this disease while cases are still on the decline. At the national level, syphilis elimination is defined as the absence of sustained transmission in the United States. At the local level, syphilis elimination is defined as the absence of transmission of new cases within the jurisdiction except within 90 days of report of an imported index case. It is anticipated that these definitions will translate to <1,000 cases (0.4/100,000 population) of P&S syphilis reported nationally each year. The national goal, therefore, is to reduce P & S syphilis cases to 1,000 or fewer and to increase the number of syphilis-free counties to 90% by 2005. While many other endemic diseases such as polio, measles, and smallpox have been eliminated through widespread use of vaccines, the strategies for syphilis elimination differ from these efforts largely because there is currently no vaccine. Past experience shows that continuing current STD prevention and control efforts, alone, will not be sufficient. New strategies are also required. Combining intensified traditional approaches with innovative approaches can generate new synergy and enhance the effectiveness of syphilis elimination efforts. Furthermore, the plan will evolve over time as new lessons are learned and applied. There are five strategies that are critical for eliminating syphilis from the United States. Two cross-cutting strategies, enhanced surveillance and strengthened community involvement, are key tools for evaluating and facilitating the implementation of the three additional intervention strategies, rapid outbreak response, expanded clinical and laboratory services, and enhanced health promotion. While national in scope, the syphilis elimination initiative focuses on areas with high syphilis morbidity and those areas with potential for syphilis re-mergence. High morbidity areas (HMAs) are areas with continuing syphilis transmission, usually signaling the need to improve preventive services and to strengthen the capacity to conduct surveillance and provide access to clinical and laboratory services. HMAs must address all five of the syphilis elimination strategies. Potential re-emergence areas (PRAs) are areas that currently experience little or no syphilis transmission but that are at significant risk for syphilis reintroduction because 1) they had a history of high syphilis rates in the 1990s or more recently; 2) they are a port or border jurisdiction or are located along migrant streams; 3) they are located along drug trafficking corridors; or 4) they include groups that are disproportionately affected by syphilis (e.g. drug users, people exchanging sex for money or drugs, men who have sex with men, and minority and migrant populations that are affected by racism, high rates of unemployment, poor educational opportunities, and poverty). PRAs should focus primarily on enhanced surveillance and rapid outbreak response. Low morbidity areas that are not PRAs will sustain the activities of a strong STD prevention program (Wasserheit 1999). The National Plan to Eliminate Syphilis from the United States is intended to serve as a resource and blueprint for the many partners vital to the success of this effort. Eliminating syphilis in the U.S. requires the commitment, investment, and collaboration of opinion leaders as well as program managers at local, state, and national levels. Members and leaders of affected communities must be involved in designing and delivering syphilis services, and have the opportunity to share ownership in interventions that improve the health status of their communities. For more detailed information regarding this national initiative, programs are urged to consult The National Plan to Eliminate Syphilis from the United States. The publication is available from the Centers for Disease Control and Prevention (CDC), and on the WorldWideWeb at http://www.cdc.gov/Stop Syphilis/ Recommendations
OTHER HIGH-RISK POPULATIONSIn addition to the populations specifically outlined in previous sections, many programs are targeting interventions at other populations, some of whose members engage in high-risk behaviors. Some of this work has been accomplished through HIV community planning groups. STD prevention programs must now build on past experience and knowledge to develop interventions that are appropriate to risk behaviors occurring in members of these populations. It is important to maintain the focus of the intervention on the risk behavior rather than the population. The concept of high risk populations has been criticized because it can stigmatize groups of persons rather than focus on behavioral, social, and other factors that put persons at risk regardless of their group categorization. STD prevention programs should identity populations that include persons engaging in high risk behaviors for transmission of STDs or persons with barriers to access for STD prevention and care services. Information indicating high risk behaviors or barriers to access among members of a particular population may be obtained through surveys or through examination of patient records to determine which demographic categories are over- or under-represented, indicating the possibilities of greater high risk behaviors in the former or barriers to access in the latter. Following are some examples of activities that some programs are conducting. Strategies to reduce barriers to care:
Strategies to identify persons engaging in high risk behaviors:
Recommendation
Page last modified: August 16, 2007 Page last reviewed: August 16, 2007 Historical Document Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention |
|||||||||||||||
|
|||||||||||||||
![]() |